Cancer Cell Therapy: Looking to the Future of CAR T Cell Manufacturing (Vol. 25, No. 8, Full Issue)

Abstract

For the month of August 2021, APBN looks at some of the progress made in cancer research. In Features, we have Yie Hou Lee and Michael Birnbaum from the Singapore-MIT Alliance for Research and Technology Critical Analytics for Manufacturing Personalized-Medicine (SMART-CAMP) to share about the future of CAR T cell manufacturing. Next, a team of researchers from the National Neuroscience Institute, National University of Singapore, and the Duke-NUS Medical School enlightens us on the difficulty of treating glioblastoma brain tumours and how they plan to address its critical issues. Then we have Dr. Chi-Jui Liu and Hsiao Yun Lu to talk about hereditary cancers and how we may improve our odds in this game of roulette. In Columns, we have an analysis by Dr. Ping-Chung Leung on the integrative use of Traditional Chinese Medicine in managing treatment outcomes of COVID-19 patients and a reflection by Dr. Chris Nave on the lessons we can take away from the development of COVID-19 vaccines. Finally, in Spotlights, we share highlights from the Vaccines World Summit 2021 and an interview with Mr. Abel Ang, Group Chief Executive of Advanced MedTech on how their new venture AbAsia Biolabs can help meet Singapore’ need for increased COVID-19 test kits as we enter a new normal.